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doi:10.1016/j.ejvs.2009.07.009Abstract A 61-year-old man presented with an acute type B aortic dissection for which
a stent-graft was introduced. He remains complication-free 4 years onwards and has since
been diagnosed with EhlerseDanlos syndrome type IV (EDS IV). His particular mutation is pre-
dicted to result in lesser levels of normal collagen and may explain his favourable outcome
from endovascular intervention.
Understanding the genotypeephenotype correlation may influence the choice of therapy
offered to patients with EDS IV.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
EhlerseDanlos syndrome (EDS) type IV is a heterogeneous
disorder caused by mutations in the COL3A1 gene which
encodes the proa1(III) chain of type III collagen. Mutations
result in extreme tissue and vessel fragility and affected207 188 2574; fax: þ44 0207
m (P.R. Taylor).
ty for Vascular Surgery. Publisheindividuals are at risk of arterial, bowel, and uterine
rupture. More than 80% will have a complication by the age
of 40 and premature death is expected, the most common
cause being arterial rupture.1
Surgical management is fraught with risk. The combi-
nation of massive haemorrhage and vessels with the
consistency of ‘‘wet tissue paper’’ has led to total mortality
rates of 7e41%.2,3 We report a case of a successful
endovascular repair of an acute type B aortic dissection in
a man with EDS IV.d by Elsevier Ltd. All rights reserved.
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A 61-year-old man experienced the sudden onset of tearing
pain in his chest and back. He had no significant medical
history, but his sister had suffered a ruptured splenic artery
aneurysm and a coeliac artery aneurysm. His father and
grandfather had died suddenly at the ages of 56 and 49.
CT demonstrated an acute Type B dissection involving
the thoracoabdominal aorta. There was no evidence of end-
organ ischaemia and he was initially treated with anti-
hypertensive drugs. On the thirteenth day, due to ongoing
pain and a diminishing right radial pulse, a thoracic stent-
graft (Gore TAG 34 mm 15 mm, Flagstaff Arizona) was
deployed via a right femoral arteriotomy. The common
femoral artery held sutures normally and did not appear to
be diseased. He made an uncomplicated recovery and was
discharged home on anti-hypertensives. Four years onwards
he remains complication-free. Subsequent sequencing of
the COL3A1 gene demonstrated a single mutation (c. 2023e
1 G> A), in the intron 30 splice acceptor site, confirming
the diagnosis of EDS IV. The predicted outcome of this
mutation is a premature stop codon. Only mRNA and
Therefore only collagen from the normal allele is present.
Cultured fibroblasts from his sister with the same mutation
secreted normal type III collagen, but only half the normal
amount.
Discussion
EDS type IV has been considered a disorder with a poor
outcome. A mean lifespan of 48 years and expected
complication rate of 80% by the age of 40 has given patients
a gloomy prognosis. In a review of 220 index patients and
199 affected relatives, 131 deaths were recorded, of which
103 were due to arterial rupture and 78 of these related to
the thoracoabdominal vasculature. Mutations in the
COL3A1 gene were identified in 135 of the index patients;
deletions, exon skips, splice site mutations and point
mutations, but no null mutations were seen. There
appeared to be no correlation between the nature or
location of the mutation and the type or frequency of major
complications.1
There is an emerging literature to support a spectrum of
clinical phenotypes with some individuals and families
enjoying near normal longevity, a lower complication rate,
and success with endovascular intervention.2e4
Three families with heterozygous null mutations have
been described in which some members have few compli-
cations and extended lifespan.5 Since the report of 220
families,1 the Collagen Diagnostic Laboratory at the
University of Washington has identified mutations in almost500 probands (Schwarze and Byers, unpublished). Of these,
15 families have mutations affecting either expression of
one allele of COL3A1 or chain association. Many of these
families have individuals with few clinical manifestations of
EDS IV.
Our case reports a man with delayed presentation of EDS
IV and a mutation suggesting a less severe phenotype. Even
before diagnosis of his EDS he underwent successful
endovascular intervention, reinforcing the evidence that
endovascular management is valuable in treating at least
some patients with EDS type IV. We propose that under-
standing the genotypeephenotype correlation may help
select patients that would do well from endovascular
therapy.
Conclusion
Classification of mutations, especially null alleles, and their
clinical effects may refine the management options for
patients with vascular manifestations of EDS IV.
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found in online version at doi: 10.1016/j.ejvs.2009.07.009.
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